These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 12210082)

  • 21. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors.
    Yin D; Xie D; Hofmann WK; Miller CW; Black KL; Koeffler HP
    Oncogene; 2002 Nov; 21(54):8372-8. PubMed ID: 12447702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
    J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
    Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
    Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
    J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
    Murao K; Kubo Y; Ohtani N; Hara E; Arase S
    Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
    Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas.
    Kishi M; Nakamura M; Nishimine M; Ikuta M; Kirita T; Konishi N
    Oral Oncol; 2005 Feb; 41(2):161-9. PubMed ID: 15695118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
    Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F
    J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.
    Esteller M; Tortola S; Toyota M; Capella G; Peinado MA; Baylin SB; Herman JG
    Cancer Res; 2000 Jan; 60(1):129-33. PubMed ID: 10646864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus.
    Robertson KD; Jones PA
    Oncogene; 1999 Jul; 18(26):3810-20. PubMed ID: 10445844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
    Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
    Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
    Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K
    Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical [corrected] detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: correlation with p16(INK4a) expression.
    Geradts J; Wilentz RE; Roberts H
    Mod Pathol; 2001 Nov; 14(11):1162-8. PubMed ID: 11706079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L; Eymin B; Brambilla E; Gazzeri S
    Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
    Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
    Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
    Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
    Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.